Home / Companies / EndoQuest Robotics

Texas Health Atlas · Houston

EndoQuest Robotics

Developing a flexible robotic Endoluminal Surgical (ELS) System for gastrointestinal procedures performed through the body's natural openings.

Location
Houston, Texas
Focus
MedTech
Stage / status
Investigational (pivotal trial)
Notes
First procedures in its PARADIGM pivotal trial were completed in 2025. The system has not received FDA clearance.
Website
endoquestrobotics.com
Last reviewed
Sep 29, 2026

Coverage

Future Health ExplainedCleared, approved, De Novo, Breakthrough: how FDA medical device pathways workWhat "FDA-cleared", "FDA-approved", De Novo, IDE and Breakthrough designation actually mean, with examples from Texas medtech companies.Sep 29, 2026

Sources

  1. www.globenewswire.com/news-release/2025/05/15/3082092/0/en/First-Procedures-Completed-with-EndoQuest-s-Endoluminal-Surgical-System-in-PARADIGM-Trial.html

Regulatory status is as stated by the company or its public filings on the review date; it changes. Work here? Send a correction or update.